Alterations in epigenetics have been identified as crucial prognostic elements and potential therapeutic targets, with studies indicating that methylation patterns of specific genes, such as RASSF1A and RUNX3, are correlated with the prognosis and recurrence of lung cancer (16, 18). Here, RUNX3 is linked to lung carcinoma.